Found: 19
Select item for more details and to access through your institution.
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.
- Published in:
- Journal of Market Access & Health Policy, 2024, v. 12, n. 1, p. 21, doi. 10.3390/jmahp12010004
- By:
- Publication type:
- Article
The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder preconvention questionnaire.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2217543
- By:
- Publication type:
- Article
The use of external controls: To what extent can it currently be recommended?
- Published in:
- Pharmaceutical Statistics, 2021, v. 20, n. 6, p. 1002, doi. 10.1002/pst.2120
- By:
- Publication type:
- Article
Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy.
- Published in:
- Health Research Policy & Systems, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12961-024-01154-2
- By:
- Publication type:
- Article
Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000605
- By:
- Publication type:
- Article
A framework for assessing the impact of accelerated approval.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0265712
- By:
- Publication type:
- Article
Commentary on "Target estimands for population-adjusted indirect comparisons".
- Published in:
- 2022
- By:
- Publication type:
- journal article
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.662642
- By:
- Publication type:
- Article
Towards a better use of scientific advice for developers of advanced therapies.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 6, p. 2459, doi. 10.1111/bcp.14672
- By:
- Publication type:
- Article
The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1013, doi. 10.1111/bcp.13524
- By:
- Publication type:
- Article
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1132, doi. 10.1002/cpt.2869
- By:
- Publication type:
- Article
Estimands and Complex Innovative Designs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1183, doi. 10.1002/cpt.2575
- By:
- Publication type:
- Article
The Impact of COVID‐19 on the Initiation of Clinical Trials in Europe and the United States.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 5, p. 1093, doi. 10.1002/cpt.2534
- By:
- Publication type:
- Article
Collaborative Platform Trials to Fight COVID‐19: Methodological and Regulatory Considerations for a Better Societal Outcome.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 2, p. 311, doi. 10.1002/cpt.2183
- By:
- Publication type:
- Article
Single‐Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 653, doi. 10.1002/cpt.1965
- By:
- Publication type:
- Article
Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 5, p. 1059, doi. 10.1002/cpt.1804
- By:
- Publication type:
- Article
Recognizing that Evidence is Made, not Born.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 4, p. 844, doi. 10.1002/cpt.1317
- By:
- Publication type:
- Article
Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article